Cancer-fighting herpes virus shown to be an effective treatment for some advanced melanoma
LOS ANGELES — The herpes simplex virus type 1 (HSV-1), which affects almost two-thirds of the world’s population and is generally associated with oral herpes, may cause painful cold sores or fever…
Read the full articleYou might also wanna read
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of VG2025 Intravenous Injection in Subjects With Advanced Solid Tumors
Conditions : Advanced Malignant Solid Tumor Interventions : Drug: Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 Injection Sponsor
Personalized mRNA vaccine shows promise in preventing melanoma recurrence when combined with immunotherapy
A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with
share.google·1mo ago
Salmonella-based delivery system enables oncolytic parvovirus to shrink solid tumors and generate antitumor immune memory
Khanduja et al. demonstrate that virus-delivering Salmonella (VDS) carries the H-1 parvovirus genome directly into cancer cells, enabling de
Científicos financiados por los Institutos Nacionales de la Salud descubren pistas sobre las lesiones precancerosas y la biología tumoral
En nuevos estudios publicados por la Red del Atlas de Tumores Humanos (HTAN) del Instituto Nacional del Cáncer (NCI), se explora la función
Personalized mRNA vaccine combined with Keytruda shows 49% reduction in melanoma recurrence risk
A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with
npr.org·21d agoPersonalized mRNA vaccine combined with Keytruda shows 49% reduction in melanoma recurrence risk
A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with
npr.org·21d ago
Non-lytic viral immunotherapy induces long-term glioblastoma survival and tumor-specific immunity without eliciting an antiviral response
A groundbreaking study unveils an RRV delivering IL-15 superagonist to glioblastoma, halting growth, extending survival, and boosting immune
Comments
Sign in to join the conversation.
No comments yet. Be the first.